Nur Ferhatlar
Research Subjects
Nur Ferhatlar has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Esma Demirhan
Univ Hlth Sci Turkey, Prof Dr Cemil Tascioglu City Hosp, Clin Phys Med & Rehabil, Istanbul, Turkiye
4 shared publications - Sevgi Atar
Univ Hlth Sci Turkey, Prof Dr Cemil Tascioglu City Hosp, Clin Phys Med & Rehabil, Istanbul, Turkiye
3 shared publications - Ömer Kuru
Univ Hlth Sci Turkey, Prof Dr Cemil Tascioglu City Hosp, Clin Phys Med & Rehabil, Istanbul, Turkiye
3 shared publications - Mustafa Tuna
Şanlıurfa Training and Research Hospital, Türkiye
1 shared publication - Selcen Kanyilmaz
Prof Dr Cemil Tascioglu City Hospital, Physical Medicine and Rehabilitation Clinic University of Health Sciences Istanbul Turkey
1 shared publication
Latest Publications
- Open Access
- 21 March 2025
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 8 (2) , 174-179
Evaluation of the physical and emotional effects of the earthquake in fibromyalgia patients
Aims: Fibromyalgia (FMS) is a soft tissue disease characterized by widespread pain and tenderness. Poor living conditions and stress can cause the symptoms of the disease to aggravate. Natural disasters such as earthquakes can also increase the severity of symptoms such as pain and sleep disturbance in fibromyalgia patients by creating physical and psychological stress. In this study, we aimed to show the physical and psychological effects of the earthquake on fibromyalgia patients. Methods: Our study is of prospective type and was conducted between 01.09.2023 and 01.11.2023. 59 earthquake victims and 50 non-earthquake victims FMS patients diagnosed with FMS according to the ACR2016 diagnostic criteria were included. All patients filled out four forms: Perceived Stress Scale (PSS) showing psychological states, Fibromyalgia Impact Questionnaire (FIQ) showing physical states, EuroQol Group (EQ5D3L) general quality of life scale showing quality of life, EQ5D3L-VAS scale showing pain conditions and Pittsburgh Sleep Quality Index showing sleep quality. Results: ASD, FIQ, EQ5D3L, EQ5D3L-VAS and Pittsburg scores of fibromyalgia patients who were earthquake victims were statistically significantly higher than FMS patients who were non earthquake victims (respectively p=0.008, p
- 21 March 2025
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 8 (2) , 174-179
Open AccessEvaluation of the physical and emotional effects of the earthquake in fibromyalgia patients
Aims: Fibromyalgia (FMS) is a soft tissue disease characterized by widespread pain and tenderness. Poor living conditions and stress can cause the symptoms of the disease to aggravate. Natural disasters such as earthquakes can also increase the severity of symptoms such as pain and sleep disturbance in fibromyalgia patients by creating physical and psychological stress. In this study, we aimed to show the physical and psychological effects of the earthquake on fibromyalgia patients. Methods: Our study is of prospective type and was conducted between 01.09.2023 and 01.11.2023. 59 earthquake victims and 50 non-earthquake victims FMS patients diagnosed with FMS according to the ACR2016 diagnostic criteria were included. All patients filled out four forms: Perceived Stress Scale (PSS) showing psychological states, Fibromyalgia Impact Questionnaire (FIQ) showing physical states, EuroQol Group (EQ5D3L) general quality of life scale showing quality of life, EQ5D3L-VAS scale showing pain conditions and Pittsburgh Sleep Quality Index showing sleep quality. Results: ASD, FIQ, EQ5D3L, EQ5D3L-VAS and Pittsburg scores of fibromyalgia patients who were earthquake victims were statistically significantly higher than FMS patients who were non earthquake victims (respectively p=0.008, p
- 1 August 2023
- Published by Galenos Yayinevi in Turkish Journal of Osteoporosis
- Vol. 29 (2) , 84-88
Retrospective Comparison of the Effect of IL-17 Blocker Therapy and Anti-TNF Agent Therapy on Bone Mineral Density in Axial Spondyloartropathy Patients
- 1 August 2023
- Published by Galenos Yayinevi in Turkish Journal of Osteoporosis
- Vol. 29 (2) , 84-88
Retrospective Comparison of the Effect of IL-17 Blocker Therapy and Anti-TNF Agent Therapy on Bone Mineral Density in Axial Spondyloartropathy Patients
- Open Access
- 21 October 2022
- Published by Lycia Press London UK in Medical Science and Discovery
- Vol. 9 (10) , 566-570
The Effect of Neuropathic Pain on Sleep Quality in Patients with Axial Spondyloarthritis
Objective: This study aims to determine whether neuropathic pain (NP) presence affects sleep quality in patients with axial spondyloarthritis (AxSpA). Materials and Methods: Demographic data of the patients were documented. The patient's NP was evaluated with painDETECT questionnaire. Pittsburgh Sleep Quality Index (PSQI), Ankylosing Spondylitis Quality of Life (AsQoL), Ankylosing Spondylitis Disease Activity Score (ASDAS-CRP), and visual analog scale (VAS) were used to evaluate sleep quality, quality of life (QoL), pain severity and disease activity, respectively. Results: Among the 108 patients who participated in the researh, 51 were female and 57 were male. NP was found in 41.7% of them. 65.7% Of all patients had a sleep disorder. AxSpA patients with NP had a statistically significant higher VAS-activity, VAS-night, and VAS-rest scores (p<0.001, p<0.001, p=0.002, respectively). They also had higher ASQoL scores and higher disease activity. (p=0.008, p=0.012, respectively). Although impaired sleep was detected in 71.1% of AxSpA patients with NP, it was present in 61.9% of AxSpA patients without NP, and we didn’t find a statistically significant difference (p=0.32). Total painDETECT scores were correlated with PSQI ASQoL, and VAS scores (p< 0.001). But there was no correlation with ASDAS-CRP scores (p=0.57). Conclusion: A large majority of AxSpA patients have a sleep problem, independent of the presence of NP. Not only targeting the inflammatory pain but also targeting NP and sleep disorder together in the follow-up of patients with AxSpA will improve QoL.
- 21 October 2022
- Published by Lycia Press London UK in Medical Science and Discovery
- Vol. 9 (10) , 566-570
Open AccessThe Effect of Neuropathic Pain on Sleep Quality in Patients with Axial Spondyloarthritis
Objective: This study aims to determine whether neuropathic pain (NP) presence affects sleep quality in patients with axial spondyloarthritis (AxSpA). Materials and Methods: Demographic data of the patients were documented. The patient's NP was evaluated with painDETECT questionnaire. Pittsburgh Sleep Quality Index (PSQI), Ankylosing Spondylitis Quality of Life (AsQoL), Ankylosing Spondylitis Disease Activity Score (ASDAS-CRP), and visual analog scale (VAS) were used to evaluate sleep quality, quality of life (QoL), pain severity and disease activity, respectively. Results: Among the 108 patients who participated in the researh, 51 were female and 57 were male. NP was found in 41.7% of them. 65.7% Of all patients had a sleep disorder. AxSpA patients with NP had a statistically significant higher VAS-activity, VAS-night, and VAS-rest scores (p<0.001, p<0.001, p=0.002, respectively). They also had higher ASQoL scores and higher disease activity. (p=0.008, p=0.012, respectively). Although impaired sleep was detected in 71.1% of AxSpA patients with NP, it was present in 61.9% of AxSpA patients without NP, and we didn’t find a statistically significant difference (p=0.32). Total painDETECT scores were correlated with PSQI ASQoL, and VAS scores (p< 0.001). But there was no correlation with ASDAS-CRP scores (p=0.57). Conclusion: A large majority of AxSpA patients have a sleep problem, independent of the presence of NP. Not only targeting the inflammatory pain but also targeting NP and sleep disorder together in the follow-up of patients with AxSpA will improve QoL.
- Open Access
- 29 January 2022
- Published by Anadolu Klinigi Tip Bilimleri Dergisi in Anadolu Kliniği Tıp Bilimleri Dergisi
- Vol. 27 (1) , 16-21
How does fibromyalgia affect sleep quality and quality of life in patients with metabolic syndrome?
Aim: In this study, we aimed to investigate the prevalence of fibromyalgia syndrome (FMS) in patients with metabolic syndrome (MetS) and its effects on sleep quality and quality of life (QoL).Methods: The study included a total of 84 (56 females, 28 males) patients with MetS, with a mean age of 57.5 (34–74) years and mean body mass index of 32.5 (25–48.9) kg/m2. MetS was defined according to the National Cholesterol Education Program Adult Treatment Panel III criteria. The FMS diagnosis was made based on the 2013 American College of Rheumatology Alternative Criteria. QoL and sleep quality were evaluated by the Short Form 36 (SF-36) and the Pittsburgh Sleep Quality Index, respectively.Results: All patients had diabetes mellitus and were obese or overweight. Of all patients, 73.8% had poor sleep quality and 51.2% had FMS. Patients with both MetS and FMS had a statistically significant female predominance (p<0.001). Impaired sleep was present in 62.9% of patients with both MetS and FMS and 37.1% of patients with MetS only (p<0.001). All SF-36 domain scores were statistically significantly lower in the MetS+FMS group than in the MetS group (p<0.001)Conclusion: The frequency of FMS is high in patients with MetS. Sleep quality and QoL are impaired in the presence of FMS or MetS alone. The co-presence of these conditions causes poorer sleep quality and worse QoL. FMS should be considered in the treatment and followup of patients with MetS.
- 29 January 2022
- Published by Anadolu Klinigi Tip Bilimleri Dergisi in Anadolu Kliniği Tıp Bilimleri Dergisi
- Vol. 27 (1) , 16-21
Open AccessHow does fibromyalgia affect sleep quality and quality of life in patients with metabolic syndrome?
Aim: In this study, we aimed to investigate the prevalence of fibromyalgia syndrome (FMS) in patients with metabolic syndrome (MetS) and its effects on sleep quality and quality of life (QoL).Methods: The study included a total of 84 (56 females, 28 males) patients with MetS, with a mean age of 57.5 (34–74) years and mean body mass index of 32.5 (25–48.9) kg/m2. MetS was defined according to the National Cholesterol Education Program Adult Treatment Panel III criteria. The FMS diagnosis was made based on the 2013 American College of Rheumatology Alternative Criteria. QoL and sleep quality were evaluated by the Short Form 36 (SF-36) and the Pittsburgh Sleep Quality Index, respectively.Results: All patients had diabetes mellitus and were obese or overweight. Of all patients, 73.8% had poor sleep quality and 51.2% had FMS. Patients with both MetS and FMS had a statistically significant female predominance (p<0.001). Impaired sleep was present in 62.9% of patients with both MetS and FMS and 37.1% of patients with MetS only (p<0.001). All SF-36 domain scores were statistically significantly lower in the MetS+FMS group than in the MetS group (p<0.001)Conclusion: The frequency of FMS is high in patients with MetS. Sleep quality and QoL are impaired in the presence of FMS or MetS alone. The co-presence of these conditions causes poorer sleep quality and worse QoL. FMS should be considered in the treatment and followup of patients with MetS.